课题基金 / 基金详情

Therapeutic potential of Zinc-alpha2-Glycoprotein (AZGP1) in chronic kidney and heart disease

Therapeutic potential of Zinc-alpha2-Glycoprotein (AZGP1) in chronic kidney and heart disease
锌-α2-糖蛋白(AZGP1)在慢性肾病和心脏病中的治疗潜力
批准号:
361891910
负责人:
Professor Dr. Roland Schmitt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2019-12-31

项目摘要

项目成果

Professor Dr. Roland Schmitt的其他基金

相似基金

相关文献

中文摘要
翻译
锌- α - 2糖蛋白(AZGP1)是一种41 kDa的分泌蛋白,在许多不同的组织中表达。AZGP1的多效生物效应已被描述,但其生理功能尚未明确。循环的AZGP1通过肾脏被消除,因此慢性肾病患者血清中AZGP1水平升高。我们在siRNA敲低研究中观察到AZGP1在肾修复反应的调控中起重要作用。在急性损伤的情况下,AZGP1的下调导致小管去分化增加和间质纤维化增加。这些发现表明该蛋白具有肾保护、抗纤维化作用。对不同肾损伤模型中基因缺失的AZGP1-/-小鼠的分析证实了这些影响。为了阐明治疗观点,我们在初步研究中测试了AZGP1的外源性应用,发现重组AZGP1保护上皮完整性并抑制促纤维化过程。在体外,AZGP1可拮抗tgf - β依赖性肾上皮细胞和成纤维细胞的活化。我们在主动脉收缩性心肌肥厚(TAC)模型中也发现了类似的心脏保护机制。在目前的应用中,我们想要验证和扩展这些发现。为此,我们想测试外源性AZGP1在肾脏(单侧输尿管梗阻、马兜铃酸肾病、缺血/再灌注、转基因tgf - β过表达)和心脏(TAC)各种应激模型中的保护作用。同时,AZGP1条件过表达的转基因策略将用于测试单个AZGP1水平的影响,并评估AZGP1活性的差异取决于其合成的组织。最后,在翻译的第一步,进行相关性分析,以确定AZGP1在肾脏疾病患者中的保护意义。为此,我们将在透析患者中进行一项前瞻性队列研究,以评估AZGP1对心血管死亡率和发病率的预测价值。此外,我们将分析血清AZGP1与肾移植受者移植结果的相关性。总的来说,我们期望所要求的程序的结果不仅将提高我们对AZGP1作用的基本理解,而且还将使我们能够对该蛋白用于治疗目的的潜力做出现实的估计。
英文摘要
Zinc-alpha2-glycoprotein (AZGP1) is a 41 kDa secreted protein that is expressed in many different tissues. Pleiotropic bioeffects have been described for AZGP1, but the physiological function has not been conclusively clarified. Circulating AZGP1 is eliminated via the kidney so that increased serum AZGP1 serum levels occur in patients with chronic kidney disease. We have observed in siRNA knockdown studies that AZGP1 plays an important role in the regulation of the renal repair response. In the context of acute damage, kockdown of AZGP1 resulted in increased tubular dedifferentiation and increased interstitial fibrosis. These findings indicated a nephroprotective, anti-fibrotic effect of the protein. The analysis of genetically deleted AZGP1-/- mice in different renal damage models confirmed these effects. To elucidate therapeutic perspectives, we have tested the exogenous application of AZGP1 in preliminary studies and found that recombinant AZGP1 protects epithelial integrity and inhibits pro-fibrotic processes. In vitro, AZGP1 antagonized TGF-beta-dependent activation of renal epithelial cells and fibroblasts. We also found a similar mechanism of protection in the heart using the model of aorto-constrictive cardiac hypertrophy (TAC). In the present application we want to verify and expand these findings. For this purpose, we want to test the protective effect of exogenous AZGP1 in various stress models of the kidney (unilateral ureteral obstruction, aristolochic acid nephropathy, ischemia/reperfusion, transgenic TGF-beta over-expression) and the heart (TAC). In parallel, a transgenic strategy for the conditional over-expression of AZGP1 is to be used to test the effects of individual AZGP1 levels and to assess differences in AZGP1 activity depending on the tissue where it is synthesized. Finally, in a first translational step, correlation analyzes are to be carried out to determine the protective significance of AZGP1 in patients with kidney disease. For this purpose, we will perform a prospective cohort study in dialysis patients to evaluate the predictive value of AZGP1 for cardiovascular mortality and morbidity. Furthermore, we will analyze the correlation between serum AZGP1 and transplant outcome in kidney allograft recipients. Overall, we expect that the results of the requested program will not only improve our basic understanding of the role of AZGP1 but will also allow us to make a realistic estimation of the potential of this protein for therapeutic purposes.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
ZAG-a novel biomarker for cardiovascular risk in ESRD patients?
ZAG——ESRD 患者心血管风险的新型生物标志物?
DOI: 10.1016/j.kint.2018.08.010
发表时间: 2018
期刊: Kidney international
影响因子: 19.6
作者: [Schmitt R]
通讯作者: Schmitt R
Tubular Epithelial Cell Senescence Associated Secretory Phenotype: Impact on Regeneration in Acute and Chronic Kidney Disease
Mechanismen der tubulointerstitiellen Nierenfibrose im Alter
Die Rolle adulter Knochenmark-Stammzellen bei der Tubulusreparatur im akuten Nierenversagen
  • 批准号:
    5446519
  • 项目类别:
    Emmy Noether International Fellowships
  • 资助金额:
    $0.0万
  • 财政年份:
    2005
  • 负责人:
    Professor Dr. Roland Schmitt
  • 依托单位:
Pathophysiological significance of the cell cycle in acute kidney injury
国内基金
海外基金
TRPV1受体在盐敏感性高血压过程中所介导的肾脏保护作用的机理研究
  • 批准号:
    81170243
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    王幼平
  • 依托单位:
气体信号分子硫化氢对颈动脉窦压力反射感受器的调节作用及机制
  • 批准号:
    81100181
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2011
  • 负责人:
    廖莹
  • 依托单位:
HCN4在心房颤动肺静脉电位形成中作用的研究
  • 批准号:
    81000082
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    王新华
  • 依托单位:
Transient Receptor Potential 通道 A1在膀胱过度活动症发病机制中的作用
  • 批准号:
    30801141
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2008
  • 负责人:
    都书琪
  • 依托单位: